An interventional study of Practice Facilitation in Risky Health Behavior, Drinking, Alcohol and Alcohol Use Disorder, sponsored by University of North Carolina, Chapel Hill. Completed at 7 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-17.
Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Health services research
STUN Alcohol Use Now is an intervention designed to use primary care practice support services (practice facilitation) to help small to medium-size practices (10 or fewer providers) identify and provide services for people with unhealthy alcohol use. The original recruitment goal was 135 primary care practices in North Carolina, which we were unable to meet due to pandemic-related barriers.
STUN Alcohol Use Now is an intervention designed to use primary care practice support services (practice facilitation or PF) to help small to medium-size practices (10 or fewer providers) identify and provide services for people with unhealthy alcohol use. 135 primary care practices in North Carolina will be recruited.
Specific Aim 1 will evaluate the effect of PF on uptake of evidence-based screening and brief intervention (SBI) for unhealthy alcohol use. The investigators hypothesize that PF will increase screening for unhealthy alcohol use and provision of brief counseling. The secondary hypothesis is that practice-level and contextual factors (capacity for quality improvement, organizational readiness to implement change, and implementation climate) will moderate the effect of PF on use of evidence-based screening and brief intervention (SBI) for unhealthy alcohol use.
Specific Aim 2 will evaluate whether PF increases provision, among those identified as having an alcohol use disorder (AUD), provision of medication assisted treatment (MAT) or referral to specialty care.
Aim 3 (effect of providing embedded telehealth services) will not be evaluated due to lower enrollment than anticipated and delayed data collection (both related to the COVID-19 pandemic) which have prevented randomization among practices with slower uptake of SBI after 6 months of PF.
In Aim 4 the investigators will evaluate the effect of PF on the implementation of clinical practice and office systems changes to improve evidence-based SBI and MAT. The primary hypothesis is that PF will increase implementation of clinical practice and office systems changes to improve evidence-based SBI and MAT. The secondary hypotheses are that (a) practice capacity for quality improvement (QI), organizational readiness to implement change, and contextual factors will moderate the effect of PF on the implementation of clinical practice and office systems changes and (b) embedded telehealth services will increase implementation of clinical practice and office systems changes among practices with slower uptake.
Exclusion Criteria:
All enrolled practices will receive practice facilitation for the duration of the intervention period.
Other: Practice Facilitation
1. Implementing evidence-based protocols and the use of clinical algorithms (for screening, counseling, referral, and MAT) to engage the entire clinical team in a high standard delivery of care. 2. Promoting a strong use of decision support tools and templates to support the practice workflow. 3. Optimizing the use of the electronic health record (EHR) to pull clinical data on a monthly basis to guide the change process. 4. Developing patient registries (e.g., for those identified to have AUD) to identify needed care 5. Proactive, team-based care with assigned roles and responsibilities to prepare the clinical team to develop needed care and engage patients throughout the entire visit process. 6. Enhancing the understanding of available counseling and referral resources to ensure that practices are confident that they have appropriate evidence-based intervention options.
Number of adults screened for unhealthy alcohol use
number aged 18 or older who were screened with a validated tool for unhealthy alcohol use
Time frame: 18 months
Number of adults screened for unhealthy alcohol use
number aged 18 or older who were screened with a validated tool for unhealthy alcohol use
Time frame: 12 months
Number of adults screened for unhealthy alcohol use
number aged 18 or older who were screened with a validated tool for unhealthy alcohol use
Time frame: 6 months
Percent of adults screened for unhealthy alcohol use
percent of those aged 18 or older who were screened with a validated tool for unhealthy alcohol use
Time frame: 18 months
Percent of adults screened for unhealthy alcohol use
percent of those aged 18 or older who were screened with a validated tool for unhealthy alcohol use
Time frame: 12 months
Percent of adults screened for unhealthy alcohol use
percent of those aged 18 or older who were screened with a validated tool for unhealthy alcohol use
Time frame: 6 months
Number of adults with a positive screen for unhealthy alcohol use
Of those aged 18 or older who were screened for unhealthy alcohol use, number who had a positive initial screening result
Time frame: 18 months
Number of adults with a positive screen for unhealthy alcohol use
Of those aged 18 or older who were screened for unhealthy alcohol use, number who had a positive initial screening result
Time frame: 12 months
Number of adults with a positive screen for unhealthy alcohol use
Of those aged 18 or older who were screened for unhealthy alcohol use, number who had a positive initial screening result
Time frame: 6 months
Percent of adults with a positive screen for unhealthy alcohol use
Of those aged 18 or older who were screened for unhealthy alcohol use, percentage who had a positive initial screening result
Time frame: 18 months
Percent of adults with a positive screen for unhealthy alcohol use
Of those aged 18 or older who were screened for unhealthy alcohol use, percentage who had a positive initial screening result
Time frame: 12 months
Percent of adults with a positive screen for unhealthy alcohol use
Of those aged 18 or older who were screened for unhealthy alcohol use, percentage who had a positive initial screening result
Time frame: 6 months
Number of adults provided with brief counseling for risky drinking
Of those aged 18 or older who were identified as having unhealthy alcohol use, number who received brief counseling (based on documentation in the medical record)
Time frame: 18 months
Number of adults provided with brief counseling for risky drinking
Of those aged 18 or older who were identified as having unhealthy alcohol use, number who received brief counseling (based on documentation in the medical record)
Time frame: 12 months
Number of adults provided with brief counseling for risky drinking
Of those aged 18 or older who were identified as having unhealthy alcohol use, number who received brief counseling (based on documentation in the medical record)
Time frame: 6 months
Percent of adults provided with brief counseling for risky drinking
Of those aged 18 or older who were identified as having unhealthy alcohol use, percentage who received brief counseling (based on documentation in the medical record)
Time frame: 18 months
Percent of adults provided with brief counseling for risky drinking
Of those aged 18 or older who were identified as having unhealthy alcohol use, percentage who received brief counseling (based on documentation in the medical record)
Time frame: 12 months
Percent of adults provided with brief counseling for risky drinking
Of those aged 18 or older who were identified as having unhealthy alcohol use, percentage who received brief counseling (based on documentation in the medical record)
Time frame: 6 months
Number of adults identified as having alcohol use disorder (AUD)
After screening, number of adult patients identified to have AUD (based on documented ICD diagnoses of AUD)
Time frame: 18 months
Number of adults identified as having alcohol use disorder (AUD)
After screening, number of adult patients identified to have AUD (based on documented ICD diagnoses of AUD)
Time frame: 12 months
Number of adults identified as having alcohol use disorder (AUD)
After screening, number of adult patients identified to have AUD (based on documented ICD diagnoses of AUD)
Time frame: 6 months
Percent of adults identified as having alcohol use disorder (AUD)
After screening, percentage of adult patients screened who were identified to have AUD (based on documented ICD diagnoses of AUD)
Time frame: 18 months
Percent of adults identified as having alcohol use disorder (AUD)
After screening, percentage of adult patients screened who were identified to have AUD (based on documented ICD diagnoses of AUD)
Time frame: 12 months
Percent of adults identified as having alcohol use disorder (AUD)
After screening, percentage of adult patients screened who were identified to have AUD (based on documented ICD diagnoses of AUD)
Time frame: 6 months
Number of adults prescribed pharmacotherapy for AUD
After screening, number of adult patients with AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
Time frame: 18 months
Number of adults prescribed pharmacotherapy for AUD
After screening, number of adult patients with AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
Time frame: 12 months
Number of adults prescribed pharmacotherapy for AUD
After screening, number of adult patients with AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
Time frame: 6 months
Percent of adults with AUD who were prescribed pharmacotherapy for AUD
After screening, percent of adult patients identified as having AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
Time frame: 18 months
Percent of adults with AUD who were prescribed pharmacotherapy for AUD
After screening, percent of adult patients identified as having AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
Time frame: 12 months
Percent of adults with AUD who were prescribed pharmacotherapy for AUD
After screening, percent of adult patients identified as having AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
Time frame: 6 months
Number of adults with AUD referred to specialty care for AUD
After screening, number of adult patients identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
Time frame: 18 months
Number of adults with AUD referred to specialty care for AUD
After screening, number of adult patients identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
Time frame: 12 months
Number of adults with AUD referred to specialty care for AUD
After screening, number of adult patients identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
Time frame: 6 months
Percent of adults with AUD referred to specialty care for AUD
After screening, percentage of adults identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
Time frame: 18 months
Percent of adults with AUD referred to specialty care for AUD
After screening, percentage of adults identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
Time frame: 12 months
Percent of adults with AUD referred to specialty care for AUD
After screening, percentage of adults identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
Time frame: 6 months
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of North Carolina, Chapel Hill